• Contact Us
Tuesday, July 1, 2025
Health Business
Advertisement
  • Home
  • News
    Kenya Joins Pfizer’s Global ‘Accord for a Healthier World’: A Boost for Equitable Access to Life-Saving Medicines and Vaccines

    Kenya Joins Pfizer’s Global ‘Accord for a Healthier World’: A Boost for Equitable Access to Life-Saving Medicines and Vaccines

    Kenya Launches National Employer Compliance Initiative to Power Universal Health Coverage

    Kenya Launches National Employer Compliance Initiative to Power Universal Health Coverage

    Why Road Safety for Pedestrians in Nairobi Remains an Afterthought

    Why Road Safety for Pedestrians in Nairobi Remains an Afterthought

    Merck Foundation Alumni Bring Specialized Healthcare to Local Communities

    Merck Foundation Alumni Bring Specialized Healthcare to Local Communities

  • Events
  • Private
    • KHF
    • Providers
  • Government
    • Medical Research
    • Politics & Policy
    • Regulation, Enforcement & Compliance
  • Finance
  • Tech
  • Epaper
  • Videos
  • Home
  • News
    Kenya Joins Pfizer’s Global ‘Accord for a Healthier World’: A Boost for Equitable Access to Life-Saving Medicines and Vaccines

    Kenya Joins Pfizer’s Global ‘Accord for a Healthier World’: A Boost for Equitable Access to Life-Saving Medicines and Vaccines

    Kenya Launches National Employer Compliance Initiative to Power Universal Health Coverage

    Kenya Launches National Employer Compliance Initiative to Power Universal Health Coverage

    Why Road Safety for Pedestrians in Nairobi Remains an Afterthought

    Why Road Safety for Pedestrians in Nairobi Remains an Afterthought

    Merck Foundation Alumni Bring Specialized Healthcare to Local Communities

    Merck Foundation Alumni Bring Specialized Healthcare to Local Communities

  • Events
  • Private
    • KHF
    • Providers
  • Government
    • Medical Research
    • Politics & Policy
    • Regulation, Enforcement & Compliance
  • Finance
  • Tech
  • Epaper
  • Videos
No Result
View All Result
Health Business
No Result
View All Result

Moderna starts COVID-19 vaccine trial on children less than 12 years old

by Health Business
March 17, 2021
in News, Public Health
0
Moderna starts COVID-19 vaccine trial on children less than 12 years old
Share This:

American drugmaker Moderna announced Tuesday that the first group of children participants have been vaccinated in its COVID-19 vaccine trial.

The Phase 2/3 study, called the KidCOVE study, will enroll approximately 6,750 pediatric participants in the United States and Canada ages 6 months to less than 12 years.

The trial will evaluate the safety, tolerability, reactogenicity and effectiveness of two doses of Moderna’s COVID-19 vaccine mRNA-1273 given 28 days apart, according to the company.

“We are encouraged by the primary analysis of the Phase 3 COVE study of mRNA-1273 in adults ages 18 and above, and this pediatric study will help us assess the potential safety and immunogenicity of our COVID-19 vaccine candidate in this important younger age population,” said Stephane Bancel, chief executive officer of Moderna.

In Part 1, each participant ages two years to less than 12 years may receive one of two dose levels. Also in Part 1, each participant ages six months to less than 2 years may receive one of three dose levels.

An interim analysis will be conducted to determine which dose will be used in Part 2, the placebo-controlled expansion portion of the study.

Participants will be followed through 12 months after the second vaccination. Vaccine effectiveness will either be inferred through achieving a correlate of protection, if established, or through immunobridging to the young adult population ages 18 to 25, according to Moderna.

Moderna’s COVID-19 vaccine was authorized for emergency use against COVID-19 by the U.S. Food and Drug Administration (FDA) last December, for individuals 18 years of age and older. There are three COVID-19 vaccines currently authorized for emergency use in the United States by the FDA.

Besides the one developed by Moderna, the other two are developed by American drugmaker Pfizer in partnership with German company BioNTech, and by Johnson & Johnson.

More than 110 million COVID-19 vaccine doses have been administered across the United States as of Tuesday, according to data of the U.S. Centers for Disease Control and Prevention (CDC).Over 142 million vaccine doses have been distributed across the country.

Currently, there are about 39 million Americans fully vaccinated while about 72 million have received at least one dose, CDC data show.

Share This:
Previous Post

Inside Kenya’s COVID-19 vaccine strategy

Next Post

Kenya reports 1,297 new Covid-19 cases as ministry asks counties to expand ICU facilities

Related Posts

Kenya Joins Pfizer’s Global ‘Accord for a Healthier World’: A Boost for Equitable Access to Life-Saving Medicines and Vaccines
News

Kenya Joins Pfizer’s Global ‘Accord for a Healthier World’: A Boost for Equitable Access to Life-Saving Medicines and Vaccines

June 25, 2025
Kenya Launches National Employer Compliance Initiative to Power Universal Health Coverage
News

Kenya Launches National Employer Compliance Initiative to Power Universal Health Coverage

June 25, 2025
Why Road Safety for Pedestrians in Nairobi Remains an Afterthought
News

Why Road Safety for Pedestrians in Nairobi Remains an Afterthought

June 23, 2025
Next Post
Kenya reports 1,297 new Covid-19 cases as ministry asks counties to expand ICU facilities

Kenya reports 1,297 new Covid-19 cases as ministry asks counties to expand ICU facilities

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

No Result
View All Result

Follow Us

Most Read

  • Kenya Joins Pfizer’s Global ‘Accord for a Healthier World’: A Boost for Equitable Access to Life-Saving Medicines and Vaccines

    Kenya Joins Pfizer’s Global ‘Accord for a Healthier World’: A Boost for Equitable Access to Life-Saving Medicines and Vaccines

    0 shares
    Share 0 Tweet 0
  • Why Road Safety for Pedestrians in Nairobi Remains an Afterthought

    0 shares
    Share 0 Tweet 0
  • Kenya transitions from two-test to three-test HIV algorithm for accuracy, sensitivity and specificity of diagnosis to improve linkage to care

    0 shares
    Share 0 Tweet 0
Health Business

Health Business contains need-to-know features, news and case studies that explain the administrative and commercial issues affecting healthcare and hospital management. Health Business supports several high profile exhibitions - coverage of which is always timed for maximum impact. Regular topics include ICT, Finance/Funding, Facilities Management, Security, Health & Safety. Contributors range from government ministers through to top-level health administrators and association chairs.

Top Stories

Kenya Joins Pfizer’s Global ‘Accord for a Healthier World’: A Boost for Equitable Access to Life-Saving Medicines and Vaccines

Kenya Joins Pfizer’s Global ‘Accord for a Healthier World’: A Boost for Equitable Access to Life-Saving Medicines and Vaccines

June 25, 2025
Kenya Launches National Employer Compliance Initiative to Power Universal Health Coverage

Kenya Launches National Employer Compliance Initiative to Power Universal Health Coverage

June 25, 2025
Why Road Safety for Pedestrians in Nairobi Remains an Afterthought

Why Road Safety for Pedestrians in Nairobi Remains an Afterthought

June 23, 2025

Interests

  • Events
  • Finance
  • Government
  • Magazines
  • Medical Research
  • News
  • Politics & Policy
  • Providers
  • Public Health
  • Regulation, Enforcement & Compliance
  • Technology
  • Videos

Follow Us

  • Contact Us

© 2019 | Site by Mark & Ryse.

No Result
View All Result
  • Home
  • News
  • Events
  • Private
    • KHF
    • Providers
  • Government
    • Medical Research
    • Politics & Policy
    • Regulation, Enforcement & Compliance
  • Finance
  • Tech
  • Epaper
  • Videos

© 2019 | Site by Mark & Ryse.